MDPI and ACS Style
Lau, V.; Nurkolis, F.; Park, M.N.; Heriyanto, D.S.; Taslim, N.A.; Tallei, T.E.; Permatasari, H.K.; Tjandrawinata, R.R.; Moon, S.; Kim, B.
Green Seaweed Caulerpa racemosa as a Novel Non-Small Cell Lung Cancer Inhibitor in Overcoming Tyrosine Kinase Inhibitor Resistance: An Analysis Employing Network Pharmacology, Molecular Docking, and In Vitro Research. Mar. Drugs 2024, 22, 272.
https://doi.org/10.3390/md22060272
AMA Style
Lau V, Nurkolis F, Park MN, Heriyanto DS, Taslim NA, Tallei TE, Permatasari HK, Tjandrawinata RR, Moon S, Kim B.
Green Seaweed Caulerpa racemosa as a Novel Non-Small Cell Lung Cancer Inhibitor in Overcoming Tyrosine Kinase Inhibitor Resistance: An Analysis Employing Network Pharmacology, Molecular Docking, and In Vitro Research. Marine Drugs. 2024; 22(6):272.
https://doi.org/10.3390/md22060272
Chicago/Turabian Style
Lau, Vincent, Fahrul Nurkolis, Moon Nyeo Park, Didik Setyo Heriyanto, Nurpudji Astuti Taslim, Trina Ekawati Tallei, Happy Kurnia Permatasari, Raymond R. Tjandrawinata, Seungjoon Moon, and Bonglee Kim.
2024. "Green Seaweed Caulerpa racemosa as a Novel Non-Small Cell Lung Cancer Inhibitor in Overcoming Tyrosine Kinase Inhibitor Resistance: An Analysis Employing Network Pharmacology, Molecular Docking, and In Vitro Research" Marine Drugs 22, no. 6: 272.
https://doi.org/10.3390/md22060272
